PE-backed ONS appoints Fusco as chief growth officer

Greenwich, Connecticut-based Orthopaedic & Neurosurgery Specialists, a provider of multi-specialty orthopedic and neurosurgery services, has named Christopher R. Fusco as chief growth officer. Recently, he worked at EyeCare Services Partners where he was chief development officer. ONS was backed by Kohlberg & Company.

PRESS RELEASE

Greenwich, CT – October 10, 2019 – Orthopaedic & Neurosurgery Specialists (“ONS” or the “Company”), the leading provider of multi-specialty orthopedic and neurosurgery services in Connecticut and Westchester, announced today the appointment of Christopher R. Fusco to the company’s management team as Chief Growth Officer.

Mr. Fusco joins ONS with over 12 years of experience in business development, mergers and acquisitions, physician joint ventures, operational integration, and healthcare business leadership. Most recently, he served as Chief Development Officer at EyeCare Services Partners (“ESP”), the nation’s largest vertically integrated ophthalmology-focused physician practice management company, and a Harvest Partners portfolio company. Prior to ESP, Mr. Fusco led business development at Dermatology Solutions Group, a private equity sponsored provider of dermatology services across the Southeastern U.S., and previously served as the Director of Business Development of Urgent Team, a leading independent operator of urgent care and family care centers. Mr. Fusco was formerly a member of the healthcare services and technology investment team at SV Life Sciences, a leading healthcare private equity firm, and a healthcare-focused investment banker at MTS Health Partners.

Dr. Seth Miller, MD and Dr. Mark Camel, MD, both Co-Founders and Executive Committee members of ONS, stated, “We are excited to welcome Chris to ONS to lead our growth efforts. Chris’ extensive expertise and track record of developing long-term partnerships with physicians will enhance our ability to serve more patients with the highest quality of clinical care.”
“Chris will be an excellent addition to the ONS leadership team, and his skills represent an ideal fit with our efforts to build the premier orthopedic practice in the region,” commented Robert A. Cucuel, Interim Chief Executive Officer of ONS.

“I am honored to join the ONS team at such an exciting point in their growth trajectory,” said Mr. Fusco. “By working closely alongside ONS’ physicians and management team, I look forward to supporting ONS’ continued expansion in its mission to provide the highest-quality orthopedic care.”
In July 2019, ONS announced a growth capital investment from Kohlberg & Company, L.L.C, a leading private equity firm headquartered in New York. Kohlberg partnered with ONS to position the Company for continued expansion of both its geographic footprint as well as its extensive offering of clinical care capabilities and ancillary services while serving a broader base of patients in the Tri-State area.

About Orthopaedic & Neurosurgery Specialists
ONS, headquartered in Greenwich, Connecticut, is a multi-specialty orthopedic and neurosurgery physician group with three locations in Greenwich, Stamford, and Harrison. The Company’s clinical offering covers a wide range of sub-specialties including orthopedic, sports medicine, joint replacement, neurosurgery, physiatry and ancillary services such as physical therapy and MRI. ONS partners operate an ambulatory surgery center and urgent care center.

For more information visit: www.onsmd.com.

About Kohlberg & Company, L.L.C.
Kohlberg & Company, LLC (“Kohlberg”) is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized eight private equity funds, through which it has raised over $7.5 billion of committed equity capital. Over its 32-year history, Kohlberg has completed 80 platform investments and nearly 200 add-on acquisitions, with an aggregate transaction value of over $15 billion.

For more information visit: www.kohlberg.com.